Historical award
Glaxosmithkline, LLC
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (16 days old).
Fiscal year 2026: data through (16 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $190,253.04
- Potential award value
- $190,253.04
- Total obligated to date
- $190,253.04
Source date: Nov 9, 2026
Recorded work
QUADRIVALENT FLU VACCINE IN PREFILLED SYRINGES, FEDERAL EXCISE TAX AND SHIPPING. DELIVER MID SEPTEMBER 2024 TO ALL FBI LOCATIONS. WILL NEED TO BE SHIPPED TO INDIVIDUAL OFFICES AT NO ADDITIONAL CHARGE.
Award activity
- Obligations in covered fiscal years
- −$2,243.55
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_15F06724F0001158_1549_36F79722D0178_3600